Small moleculesBiologicsBiosimilarsVaccines
Priority ReviewConditional ApprovalOrphan Drug
PATH 33INSP 362 guidance
Online portalBroad mandateView Small moleculesBiologicsVaccinesCell therapy
SAKIGAKEPriority ReviewConditional ApprovalOrphan Drug
PATH 44INSP 483 guidance
Online portalBroad mandateView MHRA
United Kingdom · United Kingdom
Small moleculesBiologicsBiosimilarsVaccines
Rolling ReviewConditional ApprovalOrphan DrugPriority Review
PATH 44INSP 602 guidance
Online portalBroad mandateView Switzerland · Switzerland
Small moleculesBiologicsBiosimilarsVaccines
Fast TrackRolling ReviewOrphan DrugConditional Approval
PATH 44INSP 482 guidance
Online portalBroad mandateView Small moleculesBiologicsBiosimilarsVaccines
Priority ReviewConditional ApprovalOrphan Drug
PATH 33INSP 362 guidance
Online portalBroad mandateView